Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00478387
Status:
COMPLETED
Last Update Posted:
2016-10-05
First Post:
2007-05-22
Brief Title:
Ovarian Cancer and Immune Response to Flu Vaccine
Sponsor:
University of Pennsylvania
Organization:
University of Pennsylvania
Study Overview
Official Title:
Study of the Immunogenicity of Killed Influenza Vaccine in Patients With Ovarian Fallopian Tube and Primary Peritoneal Cancer in Remission
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine what the immune response is of ovarian cancer patients in remission when they are given the flu vaccine After receiving the flu vaccine patients will have blood drawn 5 times in 12 months to study antibody response to the flu vaccine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| UPCC 5806 N01-A1-50024 | None | None | None |